Literature DB >> 29203862

Diversification of human plasmacytoid predendritic cells in response to a single stimulus.

Solana G Alculumbre1,2, Violaine Saint-André1,3, Jeremy Di Domizio4, Pablo Vargas1,5, Philemon Sirven1,2, Pierre Bost1,2,6, Mathieu Maurin1,2, Paolo Maiuri1,7, Maxime Wery1,3, Mabel San Roman1,2, Léa Savey8,9, Maxime Touzot10, Benjamin Terrier11, David Saadoun8,9, Curdin Conrad4, Michel Gilliet4, Antonin Morillon1,3, Vassili Soumelis12,13,14.   

Abstract

Innate immune cells adjust to microbial and inflammatory stimuli through a process termed environmental plasticity, which links a given individual stimulus to a unique activated state. Here, we report that activation of human plasmacytoid predendritic cells (pDCs) with a single microbial or cytokine stimulus triggers cell diversification into three stable subpopulations (P1-P3). P1-pDCs (PD-L1+CD80-) displayed a plasmacytoid morphology and specialization for type I interferon production. P3-pDCs (PD-L1-CD80+) adopted a dendritic morphology and adaptive immune functions. P2-pDCs (PD-L1+CD80+) displayed both innate and adaptive functions. Each subpopulation expressed a specific coding- and long-noncoding-RNA signature and was stable after secondary stimulation. P1-pDCs were detected in samples from patients with lupus or psoriasis. pDC diversification was independent of cell divisions or preexisting heterogeneity within steady-state pDCs but was controlled by a TNF autocrine and/or paracrine communication loop. Our findings reveal a novel mechanism for diversity and division of labor in innate immune cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29203862     DOI: 10.1038/s41590-017-0012-z

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  46 in total

1.  Long Noncoding RNA Signatures Induced by Toll-Like Receptor 7 and Type I Interferon Signaling in Activated Human Plasmacytoid Dendritic Cells.

Authors:  Rochelle C Joslyn; Adriana Forero; Richard Green; Stephen E Parker; Ram Savan
Journal:  J Interferon Cytokine Res       Date:  2018-09       Impact factor: 2.607

2.  Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.

Authors:  Chunmei Fu; Peng Peng; Jakob Loschko; Li Feng; Phuong Pham; Weiguo Cui; Kelvin P Lee; Anne B Krug; Aimin Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-02       Impact factor: 11.205

3.  Plasmacytoid dendritic cells: Division of labour.

Authors:  Lucy Bird
Journal:  Nat Rev Immunol       Date:  2017-12-22       Impact factor: 53.106

Review 4.  A cardioimmunologist's toolkit: genetic tools to dissect immune cells in cardiac disease.

Authors:  Anthony Wong; Homaira Hamidzada; Slava Epelman
Journal:  Nat Rev Cardiol       Date:  2022-05-06       Impact factor: 32.419

Review 5.  RNA regulatory mechanisms that control antiviral innate immunity.

Authors:  Nandan S Gokhale; Julian R Smith; Rachel D Van Gelder; Ram Savan
Journal:  Immunol Rev       Date:  2021-08-17       Impact factor: 12.988

6.  X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.

Authors:  Takaki Asano; Bertrand Boisson; Fanny Onodi; Daniela Matuozzo; Marcela Moncada-Velez; Majistor Raj Luxman Maglorius Renkilaraj; Peng Zhang; Laurent Meertens; Alexandre Bolze; Marie Materna; Richard P Lifton; Paul Bastard; Luigi D Notarangelo; Laurent Abel; Helen C Su; Emmanuelle Jouanguy; Ali Amara; Vassili Soumelis; Aurélie Cobat; Qian Zhang; Jean-Laurent Casanova; Sarantis Korniotis; Adrian Gervais; Estelle Talouarn; Benedetta Bigio; Yoann Seeleuthner; Kaya Bilguvar; Yu Zhang; Anna-Lena Neehus; Masato Ogishi; Simon J Pelham; Tom Le Voyer; Jérémie Rosain; Quentin Philippot; Pere Soler-Palacín; Roger Colobran; Andrea Martin-Nalda; Jacques G Rivière; Yacine Tandjaoui-Lambiotte; Khalil Chaïbi; Mohammad Shahrooei; Ilad Alavi Darazam; Nasrin Alipour Olyaei; Davood Mansouri; Nevin Hatipoğlu; Figen Palabiyik; Tayfun Ozcelik; Giuseppe Novelli; Antonio Novelli; Giorgio Casari; Alessandro Aiuti; Paola Carrera; Simone Bondesan; Federica Barzaghi; Patrizia Rovere-Querini; Cristina Tresoldi; Jose Luis Franco; Julian Rojas; Luis Felipe Reyes; Ingrid G Bustos; Andres Augusto Arias; Guillaume Morelle; Kyheng Christèle; Jesús Troya; Laura Planas-Serra; Agatha Schlüter; Marta Gut; Aurora Pujol; Luis M Allende; Carlos Rodriguez-Gallego; Carlos Flores; Oscar Cabrera-Marante; Daniel E Pleguezuelo; Rebeca Pérez de Diego; Sevgi Keles; Gokhan Aytekin; Ozge Metin Akcan; Yenan T Bryceson; Peter Bergman; Petter Brodin; Daniel Smole; C I Edvard Smith; Anna-Carin Norlin; Tessa M Campbell; Laura E Covill; Lennart Hammarström; Qiang Pan-Hammarström; Hassan Abolhassani; Shrikant Mane; Nico Marr; Manar Ata; Fatima Al Ali; Taushif Khan; András N Spaan; Clifton L Dalgard; Paolo Bonfanti; Andrea Biondi; Sarah Tubiana; Charles Burdet; Robert Nussbaum; Amanda Kahn-Kirby; Andrew L Snow; Jacinta Bustamante; Anne Puel; Stéphanie Boisson-Dupuis; Shen-Ying Zhang; Vivien Béziat
Journal:  Sci Immunol       Date:  2021-08-19

7.  Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cells.

Authors:  Tae Jin Yun; Suzu Igarashi; Haoquan Zhao; Oriana A Perez; Marcus R Pereira; Emmanuel Zorn; Yufeng Shen; Felicia Goodrum; Adeeb Rahman; Peter A Sims; Donna L Farber; Boris Reizis
Journal:  Sci Immunol       Date:  2021-04-02

8.  Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance.

Authors:  Dominik Aschenbrenner; Maria Quaranta; Stephen N Sansom; Holm H Uhlig; Soumya Banerjee; Nicholas Ilott; Joanneke Jansen; Boyd Steere; Yin-Huai Chen; Stephen Ho; Karen Cox; Carolina V Arancibia-Cárcamo; Mark Coles; Eamonn Gaffney; Simon Pl Travis; Lee Denson; Subra Kugathasan; Jochen Schmitz; Fiona Powrie
Journal:  Gut       Date:  2020-10-09       Impact factor: 23.059

9.  Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma.

Authors:  Rebecca L Ross; Clarissa Corinaldesi; Gemma Migneco; Ian M Carr; Agne Antanaviciute; Christopher W Wasson; Antonio Carriero; Jörg H W Distler; Steve Holmes; Yasser M El-Sherbiny; Clive S McKimmie; Francesco Del Galdo
Journal:  Ann Rheum Dis       Date:  2021-02-04       Impact factor: 19.103

10.  Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma.

Authors:  Antoni Ribas; Theresa Medina; John M Kirkwood; Yousef Zakharia; Rene Gonzalez; Diwakar Davar; Bartosz Chmielowski; Katie M Campbell; Riyue Bao; Heather Kelley; Aaron Morris; David Mauro; James E Wooldridge; Jason J Luke; George J Weiner; Arthur M Krieg; Mohammed M Milhem
Journal:  Cancer Discov       Date:  2021-12-01       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.